AVTX Annual Current Assets
$8.39 M
-$8.02 M-48.86%
31 December 2023
Summary:
As of January 23, 2025, AVTX annual total current assets is $8.39 million, with the most recent change of -$8.02 million (-48.86%) on December 31, 2023. During the last 3 years, it has fallen by -$17.61 million (-67.72%). AVTX annual current assets is now -86.43% below its all-time high of $61.84 million, reached on December 31, 2021.AVTX Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AVTX Quarterly Current Assets
$86.15 M
-$9.75 M-10.16%
30 September 2024
Summary:
As of January 23, 2025, AVTX quarterly total current assets is $86.15 million, with the most recent change of -$9.75 million (-10.16%) on September 30, 2024. Over the past year, it has dropped by -$9.75 million (-10.16%). AVTX quarterly current assets is now -22.54% below its all-time high of $111.21 million, reached on March 31, 2024.AVTX Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AVTX Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -48.9% | -10.2% |
| 3 y3 years | -67.7% | +424.8% |
| 5 y5 years | -61.7% | +584.3% |
AVTX Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -86.4% | at low | -22.5% | +1045.7% |
| 5 y | 5-year | -86.4% | at low | -22.5% | +1045.7% |
| alltime | all time | -86.4% | +103.0% | -22.5% | +2424.0% |
Avalo Therapeutics Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $86.15 M(-10.2%) |
| June 2024 | - | $95.89 M(-13.8%) |
| Mar 2024 | - | $111.21 M(+1224.8%) |
| Dec 2023 | $12.60 M(-25.7%) | $8.39 M(-33.7%) |
| Sept 2023 | - | $12.66 M(+68.4%) |
| June 2023 | - | $7.52 M(-60.9%) |
| Mar 2023 | - | $19.25 M(+17.3%) |
| Dec 2022 | $16.95 M(-7.7%) | $16.42 M(-15.6%) |
| Sept 2022 | - | $19.45 M(+29.5%) |
| June 2022 | - | $15.02 M(-65.6%) |
| Mar 2022 | - | $43.66 M(-29.4%) |
| Dec 2021 | $18.37 M(+3.5%) | $61.84 M(-19.7%) |
| Sept 2021 | - | $77.01 M(+62.6%) |
| June 2021 | - | $47.36 M(+2.8%) |
| Mar 2021 | - | $46.10 M(+77.3%) |
| Dec 2020 | $17.75 M(-3.5%) | $26.00 M(-36.6%) |
| Sept 2020 | - | $41.03 M(-18.3%) |
| June 2020 | - | $50.24 M(+97.2%) |
| Mar 2020 | - | $25.49 M(+43.8%) |
| Dec 2019 | $18.39 M | $17.72 M(+40.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2019 | - | $12.59 M(-9.4%) |
| June 2019 | - | $13.90 M(-48.0%) |
| Mar 2019 | - | $26.74 M(+21.9%) |
| Dec 2018 | $48.32 M(+50.4%) | $21.93 M(+18.7%) |
| Sept 2018 | - | $18.47 M(+56.0%) |
| June 2018 | - | $11.84 M(-11.6%) |
| Mar 2018 | - | $13.39 M(+25.5%) |
| Dec 2017 | $32.13 M(>+9900.0%) | $10.67 M(-62.0%) |
| Sept 2017 | - | $28.11 M(+372.3%) |
| June 2017 | - | $5.95 M(+72.1%) |
| Mar 2017 | - | $3.46 M(-38.9%) |
| Dec 2016 | $106.10 K(+201.4%) | $5.66 M(-40.3%) |
| Sept 2016 | - | $9.49 M(-27.7%) |
| June 2016 | - | $13.13 M(-22.3%) |
| Mar 2016 | - | $16.89 M(-21.9%) |
| Dec 2015 | $35.20 K(-77.4%) | $21.62 M(+533.5%) |
| Sept 2015 | - | $3.41 M(-45.9%) |
| June 2015 | - | $6.31 M(-30.0%) |
| Mar 2015 | - | $9.00 M(-26.0%) |
| Dec 2014 | $155.90 K(-83.4%) | $12.16 M |
| Dec 2013 | $939.80 K | - |
FAQ
- What is Avalo Therapeutics annual total current assets?
- What is the all time high annual current assets for Avalo Therapeutics?
- What is Avalo Therapeutics annual current assets year-on-year change?
- What is Avalo Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Avalo Therapeutics?
- What is Avalo Therapeutics quarterly current assets year-on-year change?
What is Avalo Therapeutics annual total current assets?
The current annual current assets of AVTX is $8.39 M
What is the all time high annual current assets for Avalo Therapeutics?
Avalo Therapeutics all-time high annual total current assets is $61.84 M
What is Avalo Therapeutics annual current assets year-on-year change?
Over the past year, AVTX annual total current assets has changed by -$8.02 M (-48.86%)
What is Avalo Therapeutics quarterly total current assets?
The current quarterly current assets of AVTX is $86.15 M
What is the all time high quarterly current assets for Avalo Therapeutics?
Avalo Therapeutics all-time high quarterly total current assets is $111.21 M
What is Avalo Therapeutics quarterly current assets year-on-year change?
Over the past year, AVTX quarterly total current assets has changed by -$9.75 M (-10.16%)